Speaker illustration

Doctor Steven Deitelzweig

Ochsner Medical Center, New Orleans (United States of America)

Incidence and delays of a new clinical atrial fibrillation diagnosis following an atrial fibrillation detection signal on a personal electrocardiogram device available to consumers

Event: ESC Congress 2023

Topic: Atrial Stressors

Session: Atrial fibrillation: beyond stroke prevention and rhythm control

Thumbnail

Clinical impact of switching or continuation of apixaban or rivaroxaban among patients with non-valvular atrial fibrillation

Event: ESC Congress 2023

Topic: Anticoagulants

Session: Oral anticoagulation in patients with atrial fibrillation

Thumbnail

Addressing the needs of patients with non-valvular atrial fibrillation and multiple comorbidities: non-vitamin K antagonist oral anticoagulant experience from trials to clinical practice.

Event: ESC Congress 2022

Topic: Atrial Fibrillation (AF)

Session: Addressing the needs of patients with non-valvular atrial fibrillation and multiple comorbidities: non-vitamin K antagonist oral anticoagulant experience from trials to clinical practice

Thumbnail

Addressing the needs of patients with non-valvular atrial fibrillation and multiple comorbidities: non-vitamin K antagonist oral anticoagulant experience from trials to clinical practice.

Event: ESC Congress 2022

Topic: Atrial Fibrillation (AF)

Session: Addressing the needs of patients with non-valvular atrial fibrillation and multiple comorbidities: non-vitamin K antagonist oral anticoagulant experience from trials to clinical practice

Thumbnail

Addressing the needs of patients with non-valvular atrial fibrillation and multiple comorbidities: non-vitamin K antagonist oral anticoagulant experience from trials to clinical practice.

Event: ESC Congress 2022

Topic: Atrial Fibrillation (AF)

Session: Addressing the needs of patients with non-valvular atrial fibrillation and multiple comorbidities: non-vitamin K antagonist oral anticoagulant experience from trials to clinical practice

Thumbnail

Real-world evidence complements randomised controlled trial data to inform daily clinical practice.

Event: ESC Congress 2022

Topic: Atrial Fibrillation (AF)

Session: Real-world evidence in practice: stroke prevention with non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation

Thumbnail

Understanding clinical practice data for anticoagulation in non-valvular atrial fibrillation (NVAF): A scenario-driven discussion of evidence beyond clinical trials.

Event: ESC Congress 2021 - The Digital Experience

Topic: Atrial Fibrillation (AF)

Session: Understanding clinical practice data for anticoagulation in non-valvular atrial fibrillation (NVAF): A scenario-driven discussion of evidence beyond clinical trials

Thumbnail

Understanding clinical practice data for anticoagulation in non-valvular atrial fibrillation (NVAF): A scenario-driven discussion of evidence beyond clinical trials.

Event: ESC Congress 2021 - The Digital Experience

Topic: Atrial Fibrillation (AF)

Session: Understanding clinical practice data for anticoagulation in non-valvular atrial fibrillation (NVAF): A scenario-driven discussion of evidence beyond clinical trials

Thumbnail

Understanding clinical practice data for anticoagulation in non-valvular atrial fibrillation (NVAF): A scenario-driven discussion of evidence beyond clinical trials.

Event: ESC Congress 2021 - The Digital Experience

Topic: Atrial Fibrillation (AF)

Session: Understanding clinical practice data for anticoagulation in non-valvular atrial fibrillation (NVAF): A scenario-driven discussion of evidence beyond clinical trials

Thumbnail

Comparison of stroke and major bleeding risk of treatment with apixaban vs. rivaroxaban and dabigatran among elderly nonvalvular atrial fibrillation patients in the United States

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Anticoagulation in atrial fibrillation

Thumbnail